SAN DIEGO -- (BUSINESS WIRE) -- Dexcom (NASDAQ:DXCM), a leader in continuous glucose monitoring, today announced that the Dexcom G4® PLATINUM, a continuous glucose monitoring system, was named the winner of two awards that recognize the device’s innovation, including the inaugural Everyday Health Award for Innovation, which was presented by wellness company, Everyday Health, and The 2014 International Consumer Electronics Show (CES) Digital Summit.
The Dexcom G4 PLATINUM was honored in the Emerging Technology category in a special live ceremony on January 9, 2014. Dexcom Chief Executive Officer, Terrance H. Gregg accepted the award on the company’s behalf. Dexcom was recognized among other innovative digital health products, for their “outstanding achievement in technology innovation aimed at improving overall health outcomes.”
Dexcom was also recognized as one of the top 10 innovative products at CES by the Tech Podcast Network. Mr. Gregg will be featured in a podcast today, Friday, January 10, where he will be interviewed on the success of the G4 PLATINUM and where the G4 PLATINUM ranks among other products being honored.
“We are humbled by the recognition that the Dexcom G4 PLATINUM has received and especially in the presence of our peers at CES, being included as part of a unique group on the cutting edge of marrying creativity, science and technology,” said Terrance H. Gregg, CEO, Dexcom. “At Dexcom we are proud of what we have accomplished by taking technology and science a step further, innovating on behalf of people with the serious and persistent disease of diabetes.”
The Everyday Health Awards for Innovation selected three finalists in five categories among over 140 entries of incredible innovations and competitive products in the digital health industry. The finalists were selected by an expert judging panel in the digital health and wellness industry and consumers had the opportunity to vote for their favorite products, which made up for 30 percent of the winner’s votes.
The Dexcom G4 PLATINUM tracks glucose levels continuously for 7 days throughout the 24-hour period using wireless technology, enabling users to view their glucose levels on demand. The system allows persons with diabetes to program personalized information, such as glucose targets and alerts, and it has an alarm feature to alert the user if glucose levels rise or fall to dangerous levels. The Dexcom G4 PLATINUM is the only CGM that comes with a built-in alarm that notifies users when glucose levels fall to critically low levels for an additional level of awareness no other CGM brand offers.
ABOUT DEXCOM, INC.
Dexcom, Inc., headquartered in San Diego, California, develops and markets continuous glucose monitoring systems for use by persons with diabetes, as well as blood glucose monitoring systems used by healthcare providers in hospital critical care settings. For more information on the Dexcom® CGM, visit www.dexcom.com.
BRIEF SAFETY STATEMENT
The Dexcom G4 PLATINUM Continuous Glucose Monitoring System is a glucose monitoring device indicated for detecting trends and tracking patterns in persons (age 18 and older) with diabetes. CONTRAINDICATIONS: Remove the Dexcom G4 PLATINUM System before MRI, CT scan, or diathermy treatment. Taking acetaminophen while wearing the sensor may falsely raise your sensor glucose readings. WARNING: Do not use the Dexcom G4 PLATINUM for treatment decisions. The Dexcom G4 PLATINUM does not replace a blood glucose meter. If a sensor breaks and no portion of it is visible above the skin, do not attempt to remove it. Seek professional medical help if you have infection or inflammation. Report broken sensors to Dexcom Technical Support. The Dexcom G4 PLATINUM is not approved for use in children or adolescents, pregnant women or persons on dialysis. Sensor placement is not approved for sites other than under the skin of the belly (abdomen). Contact Dexcom Toll Free at 877-339-2664 or www.dexcom.com for detailed indications for use and safety information.